CARA BARRETT: Open Payments
NPI 1396179560 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,820 in 63 payments from 10 companies in 2025. Trend: 2023 $523 · 2024 $825 · 2025 $1,820
Food & beverage: $1,652Travel & lodging: $168
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 9 | $524 |
| Madrigal Pharmaceuticals | 12 | $350 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $309 |
| ABBVIE INC. | 10 | $261 |
| Gilead Sciences, Inc. | 8 | $150 |
| Novo Nordisk Inc | 4 | $104 |
| ORPHALAN INC | 3 | $64 |
| Mirum Pharmaceuticals, Inc. | 1 | $21 |
| Intra-Sana Laboratories | 1 | $21 |
| Echosens North America, Inc. | 1 | $17 |
Products named: IQIRVO, REZDIFFRA, XIFAXAN, MAVYRET, Wegovy, CUVRIOR, Livmarli, RELTONE 200 MG.
Industry payments across TN — which companies pay providers there.
